Stereotactic Ablative Radiotherapy Should Be Combined With a Hypoxic Cell Radiosensitizer
- 1 October 2010
- journal article
- editorial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 78 (2) , 323-327
- https://doi.org/10.1016/j.ijrobp.2010.04.070
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Highly tumorigenic lung cancer CD133 + cells display stem-like features and are spared by cisplatin treatmentProceedings of the National Academy of Sciences, 2009
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- A Potential Role for PTEN in the Diabetic HeartCardiovascular Drugs and Therapy, 2006
- PTEN Activity Is Modulated During Ischemia and ReperfusionCirculation Research, 2005
- Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failureJournal of Clinical Investigation, 2005
- The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and diseaseJournal of Molecular and Cellular Cardiology, 2004
- Phosphatases in cell–matrix adhesion and migrationNature Reviews Molecular Cell Biology, 2003
- Rapamycin Attenuates Load-Induced Cardiac Hypertrophy in MiceCirculation, 2003
- Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasisBritish Journal of Cancer, 2000
- Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenationThe British Journal of Radiology, 1979